PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 54 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $47,000 | -30.9% | 12,215 | -43.2% | 0.01% | -35.0% |
| Q3 2017 | $68,000 | -26.1% | 21,501 | -85.7% | 0.02% | -28.6% |
| Q2 2017 | $92,000 | -6.1% | 150,500 | 0.0% | 0.03% | -9.7% |
| Q1 2017 | $98,000 | +127.9% | 150,500 | +8.2% | 0.03% | +121.4% |
| Q4 2016 | $43,000 | -25.9% | 139,100 | +2.7% | 0.01% | -30.0% |
| Q3 2016 | $58,000 | +18.4% | 135,506 | 0.0% | 0.02% | +17.6% |
| Q2 2016 | $49,000 | -69.2% | 135,506 | 0.0% | 0.02% | -71.2% |
| Q4 2015 | $159,000 | -10.7% | 135,506 | 0.0% | 0.06% | -9.2% |
| Q3 2015 | $178,000 | 0.0% | 135,506 | 0.0% | 0.06% | 0.0% |
| Q2 2015 | $178,000 | -2.7% | 135,506 | 0.0% | 0.06% | -3.0% |
| Q1 2015 | $183,000 | -2.7% | 135,506 | 0.0% | 0.07% | -1.5% |
| Q4 2014 | $188,000 | -19.0% | 135,506 | -20.5% | 0.07% | -24.4% |
| Q3 2014 | $232,000 | -31.6% | 170,506 | -5.5% | 0.09% | -35.7% |
| Q2 2014 | $339,000 | +20.6% | 180,506 | +22.0% | 0.14% | +9.4% |
| Q1 2014 | $281,000 | +36.4% | 148,006 | 0.0% | 0.13% | +33.3% |
| Q4 2013 | $206,000 | -0.5% | 148,006 | 0.0% | 0.10% | -15.0% |
| Q3 2013 | $207,000 | +8.4% | 148,006 | 0.0% | 0.11% | -2.6% |
| Q2 2013 | $191,000 | – | 148,006 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|